Ocular Microtremor in Parkinson's Disease.
OMTinPD
1 other identifier
observational
40
1 country
2
Brief Summary
This is an exploratory, observational study that will use a novel handheld device - The iTremor ONE, which has been developed to rapidly, non-invasively assess and evaluate OMT frequency. This device uses incident laser technology directed at the sclera. PwPD who meet the inclusion criteria will participate in a home-based assessment involving cognitive, motor (using the UPDRS-III) and OMT measures. With OMT as the primary outcome, assessment with the iTremor is incredibly quick, taking just three seconds to obtain a reading. PwPD will be assessed both 'off' and on their anti-parkinsonian medication. 'Off' is defined as a 12Hr overnight washout period where participants are tested in the morning prior to their first dose. PwPD will also be invited into the laboratory to perform extensive cognitive assessments along with an assessment of balance, gait, and turning using wearable sensors. 40 PwPD, 20 with suspected PD, and 40 age-matched healthy control participants will be recruited for assessment of OMT. Ten PwPD will complete a test-retest reliability assessment at the same approx. time, exactly one week after their initial visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
September 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedApril 19, 2024
April 1, 2024
1.1 years
September 18, 2023
April 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OMT frequency (Hz)
Ocular mictoremor frequency (Hz) as measures with the iTremor ONE device
2 weeksw
Study Arms (3)
suspPD
People referred to clinic with suspected PD
confPD
People with confirmed PD
HC
Healthy controls
Eligibility Criteria
Participants will be a volunteer sample recruited from Northumbria Healthcare and Gateshead Health NHS foundation trusts. These clinics are run by Professor Richard Walker and Dr Claire McDonald (consultant geriatricians) respectively. Participants will be seen in clinic by a Movements Disorders specialist at these sites where people referred for suspected PD diagnosis and those with diagnosed PD will be identified. Potential participants will be invited to consider the study and referred to the investigators who will attend the clinics. Healthy controls could include spouses/ siblings/ other volunteer older adults.
You may qualify if:
- People with suspected PD
- People with confirmed PD
- Healthy controls
- No history of head trauma
You may not qualify if:
- PD and older adult participants will be excluded if there is any psychiatric co-morbidity,
- a history or evidence of head injury or ocular disease (such as cataracts),
- they have a clinical diagnosis of dementia or other severe cognitive impairment (measured using the MoCA with a score of \<21).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northumbria Universitylead
- Northumbria Healthcare NHS Foundation Trustcollaborator
- Gateshead Health NHS Foundation Trustcollaborator
Study Sites (2)
Gateshead Health NHS Foundation Trust
Gateshead, Tyne and Wear, NE8 4YL, United Kingdom
Northumbria Healthcare NHS Trust
North Shields, Tyne and Wear, NE29 8NH, United Kingdom
Related Publications (1)
Graham L, Vitorio R, Walker R, Godfrey A, Morris R, Stuart S. Digital measurement of ocular microtremor in Parkinson's disease: Protocol for a pilot study to assess reliability and clinical validation. PLoS One. 2025 Jan 8;20(1):e0313452. doi: 10.1371/journal.pone.0313452. eCollection 2025.
PMID: 39775540DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel Stuart, PhD
Employee
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2023
First Posted
September 25, 2023
Study Start
September 1, 2023
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
April 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make IPD available.